glutathione gbm6 patient derived xenograft Combined inhibition of de novo and nucleotide biosynthesis is synthetically lethal in glioblastoma Frontiers | Clinically relevant glioblastoma
Frontiers Clinically relevant glioblastoma patient derived xenograft models to guide drug development and identify molecular signatures International Journal of Oncology CHCHD2 mediates glioblastoma cell proliferation, mitochondrial metabolism, hypoxia induced invasion, and therapeutic resistance bioRxiv Ferroptosis driven by nanoparticles for tackling glioblastoma ScienceDirect
Pay in 4 interest-free payments of $6.22 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9



